13F tracker › Fisher Asset Management
Fisher Asset Management 13F holdings, Q3 2026
Fisher Asset Management (investment firm founded by Ken Fisher) reported 1060 US-listed positions worth $348.3B in its
Form 13F for the quarter ended September 30, 2026, filed with the SEC on November 6, 2026.
Compared with Q2 2026, the filing shows 121 new positions, 412 increased, 413 reduced, and 98 exited.
Reported value$348.3B
Positions1060
New / exited121 / 98
Quarter endedQ3 2026
Largest holdings
| Company | Value | Weight | Shares |
| Nvidia Corp Com | $21.2B | 6.1% | 92,832,145 |
| Apple Inc | $19.5B | 5.6% | 58,446,275 |
| Alphabet Inc Class A | $14.0B | 4.0% | 40,659,406 |
| Microsoft Corp | $13.9B | 4.0% | 27,143,624 |
| Ishares TR 7 10yr TR Bd ETF | $11.3B | 3.2% | 126,210,578 |
| Amazon Com Inc Com | $8.9B | 2.5% | 35,573,420 |
| Asml Hldg Nv Nys | $8.8B | 2.5% | 4,839,202 |
| Taiwan Semiconductor Manuf ADR | $8.6B | 2.5% | 18,932,587 |
| Caterpillar Inc | $8.1B | 2.3% | 9,976,487 |
| Vanguard Fds Intterm Corp | $7.8B | 2.2% | 99,629,860 |
| Goldman Sachs Group Inc | $6.4B | 1.8% | 7,081,969 |
| Eli Lilly Co | $6.3B | 1.8% | 5,424,027 |
| Merck Co Inc | $6.1B | 1.7% | 41,699,432 |
| Jpmorgan Chase Co | $5.9B | 1.7% | 17,749,268 |
| Broadcom Inc Com | $5.4B | 1.6% | 15,482,869 |
| Exxonmobil Holdings Corporatio | $5.2B | 1.5% | 31,933,523 |
| Morgan Stanley | $5.0B | 1.4% | 26,581,811 |
| Meta Platforms Inc Cl A | $5.0B | 1.4% | 6,886,946 |
| Citigroup Inc | $4.8B | 1.4% | 37,172,713 |
| Freeportmcmoran Inc | $4.8B | 1.4% | 68,111,240 |
| Ge Vernova Inc Com | $4.7B | 1.3% | 4,921,063 |
| Ishares TR 20 Yr TR Bd ETF | $4.6B | 1.3% | 59,221,357 |
| Cisco Sys Inc | $4.4B | 1.3% | 40,646,597 |
| Walmart Inc | $4.3B | 1.2% | 41,854,464 |
| Rtx Corporation Com | $4.3B | 1.2% | 23,425,882 |
New positions in Q3 2026
| Company | Value | Shares |
| Exxonmobil Holdings Corporatio | $5.2B | 31,933,523 |
| Fidelity Covington Trust Msci | $56.9M | 790,625 |
| Adi Global Distr Inc | $24.9M | 1,390,882 |
| Hanover Ins Group Inc | $19.3M | 90,183 |
| Immunovant Inc | $18.4M | 545,730 |
| Sprouts Fmrs Mkt Inc | $13.6M | 205,191 |
| Corvus Pharmaceuticals Inc | $12.0M | 1,040,606 |
| Rhythm Pharmaceuticals Inc | $10.1M | 105,999 |
| Valmont Inds Inc | $7.4M | 15,978 |
| First Ctzns Bancshares Inc Del | $5.1M | 2,497 |
| Cboe Global Markets Inc | $5.1M | 18,614 |
| Avalo Therapeutics Inc | $4.9M | 316,505 |
| Southwest Gas Holdings Inc | $2.7M | 32,956 |
| Steris Plc | $2.4M | 11,461 |
| Idacorp Inc | $1.7M | 12,979 |
Positions increased
| Company | Value | Share change | Shares |
| Nvidia Corp Com | $21.2B | +2% | 92,832,145 |
| Apple Inc | $19.5B | +1% | 58,446,275 |
| Alphabet Inc Class A | $14.0B | +2% | 40,659,406 |
| Microsoft Corp | $13.9B | +2% | 27,143,624 |
| Amazon Com Inc Com | $8.9B | +2% | 35,573,420 |
| Asml Hldg Nv Nys | $8.8B | +2% | 4,839,202 |
| Vanguard Fds Intterm Corp | $7.8B | +4% | 99,629,860 |
| Goldman Sachs Group Inc | $6.4B | +2% | 7,081,969 |
| Eli Lilly Co | $6.3B | +7% | 5,424,027 |
| Merck Co Inc | $6.1B | +8% | 41,699,432 |
| Jpmorgan Chase Co | $5.9B | +2% | 17,749,268 |
| Broadcom Inc Com | $5.4B | +2% | 15,482,869 |
| Morgan Stanley | $5.0B | +2% | 26,581,811 |
| Meta Platforms Inc Cl A | $5.0B | +1% | 6,886,946 |
| Citigroup Inc | $4.8B | +2% | 37,172,713 |
Positions reduced
| Company | Value | Share change | Shares |
| Ishares TR 7 10yr TR Bd ETF | $11.3B | -22% | 126,210,578 |
| Ubs Group Ag | $3.1B | -2% | 63,800,525 |
| Bp Plc Sponsored ADR ADR | $2.9B | -1% | 65,437,382 |
| Shell Plc ADR | $2.6B | -1% | 27,331,036 |
| Barclays Plc ADR | $2.3B | -1% | 92,918,917 |
| Gsk Plc Sponsored ADR ADR | $1.7B | -1% | 35,351,693 |
| Intuitive Surgical Inc | $1.6B | -1% | 3,876,299 |
| Blackrock Inc Com | $1.5B | -1% | 1,382,637 |
| Spotify Technology S A | $1.2B | -7% | 2,493,012 |
| Invesco Qqq Trust Series 1 | $906.0M | -3% | 1,224,740 |
| Capital One Finl Corp | $845.8M | -3% | 4,380,656 |
| Ishares Msci Europe Fn ETF | $690.0M | -7% | 17,346,632 |
| Trane Technologies Plc | $684.9M | -12% | 1,515,370 |
| Totalenergies Se Act | $636.1M | -7% | 7,439,257 |
| Carrier Global Corporation | $629.1M | -12% | 11,466,951 |
Positions exited (held in Q2 2026)
| Company | Value in Q2 2026 | Shares |
| Exxon Mobil Corp | $4.3B | 31,468,114 |
| Fabrinet | $66.3M | 117,950 |
| Resideo Technologies Inc Com | $37.0M | 1,189,585 |
| Halozyme Therapeutics Inc | $33.5M | 427,713 |
| Viridian Therapeutics Inc | $32.2M | 1,750,850 |
| Crinetics Pharmaceuticals Inc | $27.7M | 741,553 |
| Lxp Industrial Trust | $15.6M | 290,323 |
| Insulet Corp | $8.5M | 55,746 |
| Vericel Corp | $8.2M | 185,337 |
| Onterris Inc Com | $6.7M | 332,025 |
| Prosperity Bancshares Inc | $4.2M | 58,158 |
| General Mills Inc | $3.4M | 97,886 |
| Quaker Houghton | $2.8M | 17,322 |
| Dr Reddys Labs Ltd ADR | $2.6M | 180,767 |
| Biomarin Pharmaceutical Inc | $2.0M | 35,389 |
How to read this. A Form 13F lists long positions in US-listed securities at
quarter-end. It is filed up to 45 days later and does not show short positions, most derivatives, non-US holdings, cash, or
trades made after the quarter ended, so it is a historical snapshot—not a current portfolio. Values are as reported in the
filing. This page is not investment advice and does not suggest buying or selling any security.
Source: SEC EDGAR filing (Q3 2026), previous filing (Q2 2026). Updated 2026-11-11.